Engineered Extracellular Matrices as Biomaterials of Tunable Composition and Function
Source abstract
Abstract
Engineered and decellularized extracellular matrices (ECM) are receiving increasing interest in regenerative medicine as materials capable to induce cell growth/differentiation and tissue repair by physiological presentation of embedded cues. However, ECM production/decellularization processes and control over their composition remain primary challenges. This study reports engineering of ECM materials with customized properties, based on genetic manipulation of immortalized and death‐inducible human mesenchymal stromal cells (hMSC), cultured within 3D porous scaffolds under perfusion flow. The strategy allows for robust ECM deposition and subsequent decellularization by deliberate cell‐apoptosis induction. As compared to standard production and freeze/thaw treatment, this grants superior preservation of ECM, leading to enhanced bone formation upon implantation in calvarial defects. Tunability of ECM composition and function is exemplified by modification of the cell line to overexpress vascular endothelial growth factor alpha (VEGF), which results in selective ECM enrichment and superior vasculature recruitment in an ectopic implantation model. hMSC lines culture under perfusion‐flow is pivotal to achieve uniform scaffold decoration with ECM and to streamline the different engineering/decellularization phases in a single environmental chamber. The findings outline the paradigm of combining suitable cell lines and bioreactor systems for generating ECM‐based off‐the‐shelf materials, with custom set of signals designed to activate endogenous regenerative processes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Departments of Biomedicine and of Surgery University Hospital Basel University of Basel Hebelstrasse 20 CH‐4031 Basel Switzerland
Department of Biosystems Science and Engineering Eidgenössische Technische Hochschule (ETH) Zurich Mattenstrasse 26 CH‐4058 Basel Switzerland
Funding
Seventh Framework Programme · AO Foundation
References (55)
Show source-provided references
1. 10.1038/nrm390210.1038/nrm3902 ↗
2. 10.1016/j.actbio.2008.09.01310.1016/j.actbio.2008.09.013 ↗
3. 10.1073/pnas.141197511110.1073/pnas.1411975111 ↗
4. 10.1089/ten.tea.2013.076910.1089/ten.tea.2013.0769 ↗
5. 10.1016/j.bone.2014.09.00710.1016/j.bone.2014.09.007 ↗
6. 10.1016/j.molmed.2011.03.00510.1016/j.molmed.2011.03.005 ↗
7. 10.1242/jcs.00606410.1242/jcs.006064 ↗
8. 10.1016/j.ymeth.2008.01.01010.1016/j.ymeth.2008.01.010 ↗
9. 10.1002/jcb.2138610.1002/jcb.21386 ↗
10. 10.1016/j.actbio.2007.09.00610.1016/j.actbio.2007.09.006 ↗
11. 10.1016/j.biomaterials.2011.01.05710.1016/j.biomaterials.2011.01.057 ↗
12. 10.1016/j.biomaterials.2006.02.01410.1016/j.biomaterials.2006.02.014 ↗
13. 10.1038/nbt81810.1038/nbt818 ↗
14. 10.1126/science.124766310.1126/science.1247663 ↗
15. 10.1073/pnas.073738110010.1073/pnas.0737381100 ↗
16. 10.1038/nmat376610.1038/nmat3766 ↗
17. 10.1038/3505014110.1038/35050141 ↗
18. 10.1073/pnas.140460511110.1073/pnas.1404605111 ↗
19. 10.1073/pnas.050566110310.1073/pnas.0505661103 ↗
20. 10.1002/jbm.a.3187510.1002/jbm.a.31875 ↗
21. 10.1016/j.biomaterials.2012.03.08210.1016/j.biomaterials.2012.03.082 ↗
22. 10.1016/j.scr.2013.12.00610.1016/j.scr.2013.12.006 ↗
23. 10.1182/blood-2004-11-456410.1182/blood-2004-11-4564 ↗
24. 10.1038/nrm212510.1038/nrm2125 ↗
25. 10.1038/nature0447810.1038/nature04478 ↗
26. 10.1084/jem.188.9.175710.1084/jem.188.9.1757 ↗
27. 10.1097/FJC.0b013e318093ec8f10.1097/FJC.0b013e318093ec8f ↗
28. 10.1056/NEJM19980212338070610.1056/NEJM199802123380706 ↗
29. Stanley E. R. · Stem Cells · 1994 · 12 · 15
30. 10.1038/labinvest.2013.15210.1038/labinvest.2013.152 ↗
31. 10.1111/jcmm.1252610.1111/jcmm.12526 ↗
32. 10.1038/nm0603-66910.1038/nm0603-669 ↗
33. 10.1111/j.1582-4934.2007.00103.x10.1111/j.1582-4934.2007.00103.x ↗
34. 10.1016/j.bone.2009.07.08710.1016/j.bone.2009.07.087 ↗
35. 10.1242/jcs.02382010.1242/jcs.023820 ↗
36. 10.1038/nature1402110.1038/nature14021 ↗
37. 10.1038/nm.412610.1038/nm.4126 ↗
38. 10.1007/978-1-4471-5451-8_13910.1007/978-1-4471-5451-8_139 ↗
39. 10.1089/ten.2006.12.209310.1089/ten.2006.12.2093 ↗
40. 10.1016/j.biomaterials.2013.03.04010.1016/j.biomaterials.2013.03.040 ↗
41. 10.1089/ten.tec.2011.041310.1089/ten.tec.2011.0413 ↗
42. 10.22203/eCM.v024a1610.22203/eCM.v024a16 ↗
43. 10.1089/ten.teb.2008.057510.1089/ten.teb.2008.0575 ↗
44. 10.1038/nmeth.268110.1038/nmeth.2681 ↗
45. 10.22203/eCM.v019a1410.22203/eCM.v019a14 ↗
46. 10.1016/j.scr.2013.12.00610.1016/j.scr.2013.12.006 ↗
47. 10.1002/stem.43310.1002/stem.433 ↗
48. 10.1089/ten.tec.2011.041310.1089/ten.tec.2011.0413 ↗
49. 10.1002/stem.29110.1002/stem.291 ↗
50. 10.1007/BF0022580410.1007/BF00225804 ↗
51. 10.1002/bit.1075910.1002/bit.10759 ↗
52. 10.1016/j.biomaterials.2012.03.08210.1016/j.biomaterials.2012.03.082 ↗
53. 10.1002/jcb.1017410.1002/jcb.10174 ↗
54. 10.1371/journal.pmed.004000910.1371/journal.pmed.0040009 ↗
55. 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-810.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8 ↗